|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001792,
umls-concept:C0006938,
umls-concept:C0008976,
umls-concept:C0018801,
umls-concept:C0026538,
umls-concept:C0026565,
umls-concept:C0030705,
umls-concept:C0087111,
umls-concept:C0155626,
umls-concept:C0216784,
umls-concept:C1274040,
umls-concept:C1277187
|
|
pubmed:issue |
22
|
|
pubmed:dateCreated |
2005-11-30
|
|
pubmed:abstractText |
The elderly constitute an increasing proportion of acute myocardial infarction patients and have disproportionately high mortality and morbidity. Those with heart failure or impaired left ventricular left ventricular function after acute myocardial infarction have high complication and mortality rates. Little is known about outcomes with contemporary therapies in these patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
pubmed-author:AylwardPhilip E GPE,
pubmed-author:BarvikStåleS,
pubmed-author:CaliffRobert MRM,
pubmed-author:DalbyAnthony JAJ,
pubmed-author:HuangZhenZ,
pubmed-author:Marin-NetoJosé AntonioJA,
pubmed-author:McMurrayJohn J VJJ,
pubmed-author:MurinJanJ,
pubmed-author:NordlanderRolf ORO,
pubmed-author:PfefferMarc AMA,
pubmed-author:VALIANT Investigators,
pubmed-author:WeaverW DouglasWD,
pubmed-author:WhiteHarvey DHD,
pubmed-author:ZannadFaiezF,
pubmed-author:van GilstWiek HWH
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
29
|
|
pubmed:volume |
112
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3391-9
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16301343-Age Factors,
pubmed-meshheading:16301343-Aged,
pubmed-meshheading:16301343-Aged, 80 and over,
pubmed-meshheading:16301343-Angiotensin II Type 1 Receptor Blockers,
pubmed-meshheading:16301343-Captopril,
pubmed-meshheading:16301343-Cardiovascular Diseases,
pubmed-meshheading:16301343-Cause of Death,
pubmed-meshheading:16301343-Heart Failure,
pubmed-meshheading:16301343-Humans,
pubmed-meshheading:16301343-Middle Aged,
pubmed-meshheading:16301343-Morbidity,
pubmed-meshheading:16301343-Mortality,
pubmed-meshheading:16301343-Myocardial Infarction,
pubmed-meshheading:16301343-Systole,
pubmed-meshheading:16301343-Tetrazoles,
pubmed-meshheading:16301343-Treatment Outcome,
pubmed-meshheading:16301343-Valine,
pubmed-meshheading:16301343-Ventricular Dysfunction, Left
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
|
|
pubmed:affiliation |
Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand. HarveyW@adhb.govt.nz
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
